LEPTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS

Download full text PDF
Issue: 
9
Year: 
2016

A. Pashentseva, Candidate of Medical Sciences; Professor A. Verbovoy, MD; O. Kosareva, Candidate of Medical Sciences Samara State Medical University

The paper shows the most important biological effects of leptin, its role in the pathogenesis of insulin resistance and type 2 diabetes mellitus, and its effect on the development of cardiovascular diseases.

Keywords: 
endocrinology
leptin
insulin resistance
type 2 diabetes mellitus
atherosclerosis
cardiovascular diseases



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Yuan T., Zhao W., et al. Association between four adipocins and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population // Clin. Med. J. – 2010; 123 (15): 2018–22.
  2. Hirsch J., Frield S., Edens N. et al. The fat cell // Med. Clin. North. Amer. – 1989; 73: 83–95.
  3. Friedman M., Halaas J. Leptin and the regulation of body weight in mammals // Nature. – 1998; 395 (6704): 763–70.
  4. Van Harmelen V., Reynisdottir S., Eriksson P. et al. Leptin secretion from subcutaneous and visceral adipose tissue in women // Diabetes. – 1998; 47: 913–7.
  5. Saad M., Riad-Gabriel M., KhunA. et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity // J. Clin. Endocrin. Metab. – 1998; 83: 453–9.
  6. Vuagnat V., Pierroz D., Lalaoui M. et al. Evidence for a leptin- neuropeptide Y axis for the regulation of growth hormone secretion in the rat // Neuroendocrinology. – 1998; 67: 291–300.
  7. Halaas J., Gajiwala K., Maffey M. et al. Weight-reducing effects of the plasma protein encoded by the obese gene // Science. – 1995; 269: 543–6.
  8. Stephens T., Basinski M., Bristow P. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product // Nature. – 1995; 377: 530–2.
  9. Cusin I., Rohner-Jeanrenaud F., Stricker-Krongrad A. et al. The weightreducing effect of an intracerebro-ventricular bolus injection of leptin in genetically obese fa/fa rats // Diabetes. – 1996; 45: 1446–50.
  10. Shigemura N., Ohta R., Kusakabe Y. et al. Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures // Endocrin. – 2004; 145: 839–47.
  11. De Luca C., Kowalski T., Zhang Y. et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes // J. Clin. Invest. – 2005; 115 (12): 3484–93.
  12. Mauro L., Catalano S., Bossi G. et al. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression // Cancer Res. – 2007; 67 (7): 3412–21.
  13. Spiegelman B., Flier J. Adipogenesis and obesity: rounding out the big picture // Cell. – 1996; 87: 377–89.
  14. Bjorbaek C., Kahn B. Leptin signaling in the central nervous system and the periphery // Recent Prog. Horm. Res. – 2004; 59: 305–31.
  15. Flier J. Obesity wars: molecular progress confronts an expanding epidemic // Cell. – 2004; 116: 337–50.
  16. Saad M., Khan A., Sharma A. et al. Physiological insulinemia acutely modulates plasma leptin // Diabetes. – 1998; 47: 544–9.
  17. Utriainen T., Malmstrom R., Makimattila S. et al. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects // Diabetes. – 1996; 45: 1364–6.
  18. Saladin R., De Vos P., Guerre-Millo M. et al. Transient increase in obese gene expression after food intake or insulin administration // Nature. – 1995; 377: 527–9.
  19. D'Adamo M., Buongiomo E., Maroccia F. et al. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia // Diabetes. – 1998; 47: 1625–9.
  20. Kieffer T., Habener J. The adipoinsular axis: effects of leptin on pancreatic b-cells // Am. J. Physiol. – 2000; 278: 1–14.
  21. Larsson H., Elmstahl S., Ahren B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women // Diabetes. – 1996; 45 (11): 1580–4.
  22. Haffner S., Miettinen K., Mykkanen I. et al. Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/ insulin ratio in non-diabetic subjects // Int. J. Obes. – 1998; 22: 899–905.
  23. Widjaja A., Stratton I., Horn R. et al. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects // J. Clin. Endocrinol. Metab. – 1997; 82 (2): 654–7.
  24. Muoio D., Dohm G., Tapscott E. et al. Leptin opposes insulin's effects on fatty acid partitioning in muscle isolated from obese ob ob mice // Am. J. Physiol. – 1999; 276: 913–21.
  25. Lord G., Matarese G., Howard J. Leptin modulates the T-cell immune response and reverses starvation- induced immunosuppression // Nature. – 1998; 394: 897–901
  26. Margetic S., Gazzola C., Pegg G. et al. Leptin: a review of its peripheral actions and interactions // Int. J. Obes. Relat. Metab. Disord. – 2002; 26: 407–1433.
  27. Cock T., Auwerx J. Leptin: cutting the fat off the bone // Lancet. – 2003; 362: 1572–4.
  28. Budylina M.V. Vzaimootnoshenija leptina s fizicheskim i polovym razvitiem mal'chikov v pubertatnom periode. Avtoref. dis. … kand. med. nauk. Izhevsk, 2005; 21 s.
  29. Kozhevnikova A.A. Vzaimootnoshenija leptina s fizicheskim i polovym razvitiem devochek v pubertatnom periode. Avtoref. dis. … kand. med. nauk. Kazan', 2006; 23 s.
  30. Pashentseva A.B., Skudaeva E.C., Verbovoj A.F. Leptin, rezistin i insulinorezistentnost' u patsientov s saharnym diabetom 2 tipa // Terapevt. – 2011; 5: 4–8.
  31. Verbovoj A.F., Vorozhtsova E.I., Orlova T.N. Metabolicheskie pokazateli u muzhchin s saharnym diabetom 2 tipa i ishemicheskoj bolezn'ju serdtsa // Farmateka. – 2012; 9: 60–4.
  32. Verbovoj A.F., Solomonova E.S., Pashentseva A.V. Leptin, rezistin i omentin u patsientov s narushennoj tolerantnost'ju k gljukoze i saharnym diabetom 2 tipa // Izvestija vuzov. Povolzhskij region. Meditsinskie nauki. – 2012; 3: 52–7.
  33. Verbovoj A.F., Verbovaja N.I., Kapralova I.Ju. Adiponektin, leptin i drugie metabolicheskie pokazateli u bol'nyh gipotireozom // Farmateka. – 2014; 10: 67–9.
  34. Kosareva O.V., Verbovoj A.F., Sharonova L.A. Otsenka vzaimosvjazi adipokinov i parametrov uglevodnogo i zhirovogo obmenov u bol'nyh akro megaliej // Endokrinologija: novosti, mnenija obuchenie. – 2013; 1 (25): 54–7.
  35. Lembo G., Vecchione C., Fratta L. et al. Leptin induces direct vasodilation through distinct endothelial mechanisms // Diabetes. – 2000; 49 (2): 293–7.
  36. Hercule H., Schunck W., Gross V. et al. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice // Arterioscler. Thromb. Vass. Biol. – 2009; 29 (1): 54–60.
  37. Fortuno A., Rodriguez A., Gomez-Ambrosi J. et al. Leptin inhibits angiotensin Il-induced intracellular calcium increase and vasoconstriction in the rat aorta // Endocrinology. – 2002; 143 (9): 3555–60.
  38. Fomina I.A. Vzaimosvjaz' leptina i metabolicheskih pokazatelej pri pubertatno-junosheskom dispituitarizme u junoshej. Avtoref. dis. … kand. med. nauk. Samara, 2009; 25 s.
  39. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration // Diabetes. – 1999; 48 (4): 903–8.
  40. Shankar A., Xiao J. Positive relationship between plasma leptin level and hypertension // Hypertension. – 2010; 56 (4): 623–8.
  41. Korda M., Kubant R., Patton S. et al. Leptin-induced endothelial dysfunction in obesity // Am. J. Physiol. Heart Circ. Physiol. – 2008; 295: 1514–21.
  42. Zeidan A., Purdham D., Rajapurohitam V. et al. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1- dependent mechanisms and mediates stretch- induced hypertrophy // J. Pharmacol. Exp. Ther. – 2005; 315: 1075–84.
  43. Loffreda S., Yang S., Lin H. et al. Leptin regulates proinflammatory immune responses // FASEB J. – 1998; 12: 57–65.
  44. Zeidan A., Purdham D., Rajapurohitam V. et al. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II - and endothelin-1- dependent mechanisms and mediates stretch-incluced hypertrophy // J. Pharmacol. Exp. Ther. – 2005; 315 (3): 1075–85.
  45. Karaduman M., Oktenli C. Musabak U. et al. Leptin, soluble interleikin-6 receptor, C - reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atheroscloretic plague // Clin. Exp. Immunol. – 2006; 143 (3): 452–7.
  46. Singh P., Hoffmann M., Wolk R. et al. Leptin induces C-reactive protein expression in vascular endothelial cells // Arterioscler. Thromb. Vasc. Biol. – 2007; 27 (9): 302–7.
  47. Singh P., Peterson T., Barber K. et al. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells // Biochem. Biophys. Res. Com. – 2010; 392 (1): 47–52.
  48. Sobel B., Taatjes D., Schneider D. Intramural plasminogen activator inhibitortype-1 and coronary atherosclerosis // Arterioscler. Thromb. Vasc. Biol. – 2003; 23 (11): 1979–89.
  49. Volov N.A., Adamov P.B., Lebedeva A.Ju. i dr. Leptin – novyj faktor riska serdechno-sosudistyh zabolevanij // Terapevt. – 2011; 8: 50–4.
  50. Sierra-Johnson J. et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United State population // Am. J. Cardiol. – 2007; 100: 234–9.